Sat, Dec 20, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

EDHEC hedge fund indices underperformed the stock market in March

Wednesday, April 18, 2012
Opalesque Industry Update - In March, the stock markets continued to rise for the fourth consecutive month. The S&P 500 gained 3.29%, registering a 12.59% progression since the beginning of 2012. Equity implied volatility dropped sharply, settling at a level (VIX: 15.5%) near to a one year low. Fixed income markets were again contrasted, with a high grade segment confirming a downward trend (Lehman Global: -1.00%), but riskier assets characterised by slowing momentum (Credit Spread Index: 0.52%, Convertibles: 0.28%). Commodities (-2.10%) ended their rally brutally while the Dollar regained some ground (0.83%), with the pair persisting in the anti-correlated pattern adopted four months ago.

The Equity Market Neutral strategy (0.36%) performed in line with its dynamic exposure, while the more directional strategies (Long/Short Equity: 0.34%, Event Driven: 0.62%) seem to have reduced their beta faster than what the risk model suggests, capturing only a small fraction of the market performance. The Short Selling strategy lost 0.93%, thus signalling a reduced exposure after a disastrous beginning to the year.

The Convertible Arbitrage strategy (0.63%) continued to exhibit robust performance, even with the associated risk drivers weakening. The Distressed Securities strategy (0.93%) continued to show some alpha in addition to its profitable exposure to credit risk.

The global CTA strategy lost 1.94%, wiping out all the profits accumulated this year and more, thus confirming severe underperformance in 2012 (-0.59%: the worst amongst the major hedge fund strategies).

Funds of Funds, finally, only managed an unimpressive 0.11% gain, in contrast with the two rather good months previously.

Hedge Fund Strategies Mar 2012 YTD* Annual Average Return since January 2001 Annual Std Dev since January 2001 Sharpe Ratio
Convertible Arbitrage 0.63% 5.3% 6.7% 7.3% 0.36
CTA Global -1.94% -0.6% 6.4% 8.6% 0.28
Distressed Securities 0.93% 6.3% 10.5% 6.3% 1.03
Emerging Markets -1.03% 6.4% 10.5% 10.6% 0.61
Equity Market Neutral 0.36% 2.0% 4.5% 3.0% 0.17
Event Driven 0.62% 5.3% 7.9% 6.1% 0.64
Fixed Income Arbitrage 0.69% 3.1% 6.1% 4.4% 0.48
Global Macro -0.56% 2.7% 7.0% 4.4% 0.67
Long/Short Equity 0.34% 6.2% 5.4% 7.3% 0.20
Merger Arbitrage 0.18% 2.3% 5.4% 3.3% 0.44
Relative Value 0.56% 4.3% 6.5% 4.7% 0.54
Short Selling -0.93% -12.5% -0.2% 14.1% -0.30
Funds of Funds 0.11% 3.0% 3.7% 5.1% -0.06

Corporate website: Source

fg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und